Product
Supplier
Encyclopedia
Inquiry
MS10 MOTs-c buy - large image1
MS10 MOTs-c buy - image1
MS10 MOTs-c buy - image2
MS10 MOTs-c buy - image3
MS10 MOTs-c buy - image4
MS10 MOTs-c buy - image5
MS10 MOTs-c buy - image6

MS10 MOTs-c

140 Inquiries

Unit Price: Get Latest Price
CAS No.:

1627580-64-6

Grade:

Research Grade

Content:

99%

Port:

Shengzhen

Brand:

KSD

Packaging:

10 mg/vial

Price valid (until):

2026-08-31

Company Type:
Trader
Location:
China
Payment Terms:
100% TT in advance
Average Lead Time:
14 days
Qualification:
Main Products:

Semaglutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  Shop MS10 MOTs-c-Detailed Image 1


    Undissolved Lyophilized Powder (Quality Standards)
    Appearance (Color): Pure white or uniform off-white; free from yellow spots, brown patches, black specks, mold, or colored impurities; consistent coloration.
    Appearance (Form): A porous, loose, solid cake formed by vacuum freeze-drying; crisp texture. Fragmentation into loose powder due to shipping vibrations is normal and does not compromise peptide activity. The powder remains highly dry throughout; it does not absorb moisture to become soft or sticky/gelatinous, nor does it adhere extensively to the vial walls. When the vacuum seal is intact, the lyophilized cake remains firmly adhered to the bottom of the vial even when inverted.
    Packaging and Odor: Housed in a transparent, sterile vial with an aluminum cap and rubber stopper, ensuring a tight seal with no powder leakage; no condensation on the inner vial walls; virtually odorless—free from acidic, putrid, or pungent smells.

    Mechanism of Action and Specific Benefits:Boosts fat-burning efficiency and breaks through weight-loss plateaus
    Accelerates fat oxidation and boosts basal metabolism, complementing appetite-suppressing peptides (like TR); while TR controls intake, MS10 ramps up calorie expenditure—making it ideal for those facing weight-loss plateaus, high visceral fat, or a tendency to gain weight easily.
    Improves insulin resistance and stabilizes blood sugar
    Promotes glucose uptake by muscle cells and stabilizes fasting and post-meal blood sugar levels; suitable for individuals with PCOS, carbohydrate intolerance, or impaired glucose tolerance, helping to reduce fat storage and drowsiness caused by high-sugar diets.
    Enhances exercise endurance and accelerates recovery
    Boosts mitochondrial energy production, significantly increasing endurance for both aerobic and strength training; greatly alleviates post-workout muscle soreness and helps those with sedentary lifestyles or physical weakness who tire easily or lack energy.
    Anti-aging and antioxidant support; combats fatigue from staying up late
    Endogenous MOTS-c levels decline with age; exogenous supplementation reduces mitochondrial oxidative damage, alleviating the day-long grogginess and energy depletion caused by chronic sleep deprivation and high stress, while also providing anti-aging benefits.
    Target audience: Individuals at a weight-loss plateau; fitness enthusiasts seeking better endurance or faster recovery; those with insulin resistance or PCOS; individuals with chronic fatigue or physical weakness due to staying up late; and sedentary people with slow metabolism, cold sensitivity, or a tendency to gain weight. Does not directly build muscle or repair injuries; primarily focuses on optimizing metabolism and physical performance.

    Items Specifications
    MS10 10 mg/vial,10vial/kit
    MS40 40mg*10vials,10vial/kit


    Shop MS10 MOTs-c-Detailed Image 2
    Shop MS10 MOTs-c-Detailed Image 3 Shop MS10 MOTs-c-Detailed Image 4
    ECHEMI Editorial Reference

    MOTS-c is a 16-amino-acid mitochondria-derived peptide encoded by a short open reading frame within the mitochondrial 12S rRNA region. It is associated with the folate-AICAR-AMPK signaling pathway and has been studied for its role in cellular metabolic regulation. As a peptide research and pharmaceutical raw material, MOTS-c is suitable for biochemical research, analytical studies, and pharmaceutical development.


    MOTS-C Synthetic is a single, non-glycosylated polypeptide chain containing 16 amino acids, having a molecular mass of 2174.59 Dalton and a Molecular formula of C10H152N280O22 S2.

    Basic Info
    Product Name:

    MOTS-c

    Other Name:

    MOTS-c;L-Arginine, L-methionyl-L-arginyl-L-tryptophyl-L-glutaminyl-L-α-glutamyl-L-methionylglycyl-L-tyrosyl-L-isoleucyl-L-phenylalanyl-L-tyrosyl-L-prolyl-L-arginyl-L-lysyl-L-leucyl-;MOTS-C acetate;Cosmetic Peptide Mots-C;MOTS-c POWDER;MOTS-c peptide;MOTS-c 5mg/10mg;H-Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg-OH

    CAS No.:

    1627580-64-6

    Molecular Formula:

    C101H152N28O22S2

    InChIKeys:

    WYTHCOXVWRKRAH-JIJBDQHHNA-N

    Molecular Weight:

    2174.62

    Exact Mass:

    2174.1110958

    EC Number:

    200-001-8

    Color/Form:

    Solid lyophilized powder

    Categories:

    Polypeptide

    Characteristics
    Density:

    1.44±0.1 g/cm3(Predicted)

    Critical Temperature & Pressure:

    Store at -20°C

    Research
    Class:

    Mitochondrial-derived peptide (MDP), 16-amino-acid peptide

    Status:

    Research compound — Not FDA approved

    Mechanism:

    MOTS-c (mitochondrial ORF of the twelve S rRNA-c) is a 16-amino-acid peptide encoded by the mitochondrial genome (not nuclear DNA). It is a mitochondrial-derived peptide that regulates metabolic homeostasis by activating the AMPK/PGC-1\u03b1 pathway, improving insulin sensitivity, and enhancing exercise capacity. MOTS-c crosses the blood-brain barrier and has been shown to reduce body weight and improve glucose tolerance in preclinical models.

    Activity note:

    MOTS-c does not act via a traditional receptor. It functions as a metabolic regulator, activating AMPK. Functional effects are observed at micromolar concentrations in cell-based assays.

    Source:

    Lee C, et al. Cell Metab. 2015;21(3):443-454. MCE: MOTS-c (CAS 1627580-64-6).DOI

    References
    PubChem:

    PubChem

    Disclaimer:

    MOTS-c is NOT FDA-approved or EMA-approved. It is a research compound only. All data are from preclinical (cell/animal) studies; no human clinical trials have been completed. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Semaglutide

    Location:

    Licheng District, Jinan City, Shandong Province

    Payment Terms:

    100% TT in advance

    Average lead Time:

    14 days

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    5-10

    Year of Establishment:

    2026

    Company Certificates
    • Jinan Kangshengda Technology Co., Ltd.Retatrutide coa Retatrutide coa
    Hello and welcome to learn about Kangshengda Biotechnology! We are a specialized enterprise dedicated to the R&D and production of peptide products. Leveraging high-quality peptide preparations, our core strength lies in supporting customers to achieve long-term weight management and all-round health regulation.
    Boasting extensive mature export experience, our products are sold to Europe, the United States and numerous other countries and regions worldwide. Supported by consistent, reliable product quality, efficient on-time delivery and a comprehensive professional after-sales service system, we have built long-term, solid strategic partnerships with overseas distributors.
    We are committed to delivering one-stop customized premium peptide solutions for all clients, and seek long-term development and win-win cooperation alongside domestic and global partners!
    KSD
    ">KSD
  • Inquiry History
    140 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Mots-C CAS 1627580-64-6

    5 G Apr 26, 2026
    United States

    Bodygrowth Peptides CAS 1627580-64-6 MOTS-c (Human) Acetate peptides powder

    1 G Feb 23, 2026
    United States

    MOTS-c (Human) Acetate peptides powder

    1 G Mar 12, 2026
    Brazil

    MOTS-c 10mg Peptide Raw Material High Purity

    10 PCS Feb 17, 2026
    United States

    Mots-C

    1 KG Sep 12, 2025
    United States

    MOTS-c

    1 MT Sep 25, 2026
    Canada

    Mots-C

    10 G Sep 13, 2026
    United States

    mots-c

    40 MG Sep 3, 2026
    New Zealand

    Mots-c

    1 MT Aug 20, 2026
    United Kingdom

    mots-c

    15 MG Aug 3, 2026
    United States

    Mots c

    10 MG Jul 23, 2026
    United States

    MOTS-c

    20 MG Jul 21, 2026
    Azerbaijan

    Mots-c

    5 G Jun 25, 2026
    United States

    MOTS-c

    500 MT Jun 22, 2026
    United States

    Mots-c

    1 MT Jun 16, 2026
    Australia

    MOTS-c 50mg

    30 PCS May 25, 2026
    United States

    Mots C

    4000 MG May 20, 2026
    China

    Mots-C

    10000 MT May 19, 2026
    Brazil

    most-C

    1 KG May 12, 2026
    Canada

    Mots-c

    1 KG Apr 23, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.